Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Giboin · SciRah

Researcher profile · Semantic Scholar

C. Giboin

Share profile

C. Giboin — researcher profile on SciRah

h-index: 5
Works: 16
Citations: 79

Most-cited papers

Factors associated with the choice of the first biologic in psoriasis: real‐life analysis from the Psobioteq cohort
E. Sbidian, C. Giboin, H. Bachelez, C. Paul +18 more
2017Journal of the European Academy of Dermatology and Venereology34 citations Open access
Semantic Scholar
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq
Florence Assan, F. Tubach, H. Arlegui, M. Viguier +12 more
2021Dermatology13 citations
Semantic Scholar
Perioperative management of oral anticoagulated patients undergoing an oral, implant, or periodontal procedure: a survey of practices of members of two dental scientific societies, the PRADICO study
L. Radoï, D. Hajage, C. Giboin, L. Maman +3 more
2019Clinical Oral Investigations8 citations
Semantic Scholar
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
J. Kędra, P. Dieudé, C. Giboin, H. Marotte +31 more
2023Arthritis & Rheumatology7 citations Open access
Semantic Scholar
Baclofen destabilises breathing during sleep in healthy humans: A randomised, controlled, double‐blind crossover trial
C. Straus, Marion Teulier, S. Morel, N. Wattiez +9 more
2020British Journal of Clinical Pharmacology7 citations
Semantic Scholar
Sensitivity and Specificity of Strategies to Identify Patients with Haemostasis Abnormalities Leading to an Increased Risk of Bleeding Before Scheduled Intervention: the Hemorisk Study.
N. Ajzenberg, D. Longrois, Dorothée Faille Pharma D, C. de Tymowski +21 more
2024Journal of Thrombosis and Haemostasis3 citations Open access
Semantic Scholar
Impact of methotrexate administration route on drug survival in psoriasis: Results from PSOBIOTEQ
C. Paris, R. Curmin, L. Gouillon, C. Giboin +14 more
2025Journal of the European Academy of Dermatology and Venereology2 citations
Semantic Scholar
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.
P. Loubet, Sébastien Czernichow, C. Giboin, Ariane Sultan +19 more
2026Clinical Infectious Diseases1 citations
Semantic Scholar
Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.
E. Fouka, A. Bansal, K. Håkansson, F. Jaun +90 more
2026The Lancet Respiratory Medicine1 citations Open access
Semantic Scholar
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP.
M. Caminati, J. Charriot, A. Bansal, Shane Hanon +44 more
2026American Journal of Respiratory and Critical Care Medicine1 citations Open access
Semantic Scholar
DOP013 Risk of immune mediated inﬂammatory diseases associated with anti-TNFs and ustekinumab in Crohn’s disease: a nationwide population-based cohort study
J. K. MD-Phd, C. Giboin, R. Curmin, F. Tubach
2025Journal of Crohn's & Colitis1 citations
Semantic Scholar
Progression radiographique après décroissance de l’abatacept et du tocilizumab au cours de la polyarthrite rhumatoïde en rémission prolongée : résultats de l’essai ToLEDO (Towards the Lowest Efficacious Dose)
J. Kedra, P. Dieudé, H. Marotte, C. Giboin +31 more
20201 citations
Semantic Scholar
P-1495. Immunogenicity and Safety of Recombinant High-Dose Compared to Egg-Based Standard-Dose Influenza Vaccine in Adults Living with Severe Obesity
P. Loubet, Sébastien Czernichow, C. Giboin, Ariane Sultan +19 more
2026Open Forum Infectious Diseases0 citations
Semantic Scholar
206: BIOLOGICS IN CROHN’S DISEASE AND RISK OF IMMUNE MEDIATED INFLAMMATORY DISEASES: A NATIONWIDE POPULATION-BASED COHORT STUDY
Julien Kirchgesner, C. Giboin, R. Curmin, Florence Tubach
2025Gastroenterology0 citations
Semantic Scholar
Risque de maladies inflammatoires à médiation immunitaire associé aux anti-TNF et à l'ustékinumab chez les patients atteints de maladie de Crohn : étude des données du système national des données de santé (SNDS).
J. Kirchgesner, C. Giboin, R. Curmin, F. Tubach
2025Journal of epidemiology and population health0 citations Open access
Semantic Scholar
Towards the lowest eﬀicacious dose (ToLEDo): results of a multicenter non-inferiority randomized open-label controlled trial assessing Tocilizumab or Abatacept injection spacing in rheumatoid arthritis in remission
J. Kędra, P. Dieudé, C. Giboin, H. Marotte +31 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Beylot-Barry×3
Invite
M. Beylot-Barry — researcher profile on SciRah
N. Bénéton×3
Invite
N. Bénéton — researcher profile on SciRah
D. Hajage×3
Invite
D. Hajage — researcher profile on SciRah
P. Dieudé×3
Invite
P. Dieudé — researcher profile on SciRah

×3

Invite

H. Marotte — researcher profile on SciRah

A. Perdriger×3

Invite

A. Perdriger — researcher profile on SciRah

Invite

M. Soubrier — researcher profile on SciRah

A. Constantin×3

Invite

A. Constantin — researcher profile on SciRah

Invite

E. Dernis — researcher profile on SciRah

E. Pertuiset×3

Invite

E. Pertuiset — researcher profile on SciRah

Invite

P. Gaudin — researcher profile on SciRah

Invite

G. Cormier — researcher profile on SciRah